Search Results - "Werkgartner, G"

Low skeletal muscle mass outperforms the Charlson Comorbidity Index in risk prediction in patients undergoing pancreatic resections by Wagner, D., Marsoner, K., Tomberger, A., Haybaeck, J., Haas, J., Werkgartner, G., Cerwenka, H., Bacher, H., Mischinger, H.J., Kornprat, P.

“…Low skeletal muscle mass is a known predictor of morbidity and mortality in patients undergoing major pancreatic surgeries. We sought to combine low skeletal…”
Get full text

Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome (Br J Surg 2007; 94: 1386-1394) by Werkgartner, G.

Get full text

Sarcopenia outperforms the Charlson Comorbidity Index in risk prediction in patients undergoing pancreatic resections by Wagner, D, Marsoner, K, Tomberger, A, Cerwenka, H, Werkgartner, G, Mischinger, H.J, Kornprat, P

Get full text

Laparoscopic versus open appendectomy for complicated appendicitis in high risk patients by Werkgartner, G., Cerwenka, H., El Shabrawi, A., Bacher, H., Hauser, H., Mischinger, H. J., Wagner, M., Wagner, D.

“…Introduction Laparoscopic appendectomy is widely used for the treatment of complicated appendicitis. Its use in patients with high operative risk is still on…”
Get full text

Long-term quality of life of liver transplant recipients beyond 60 years of age by Werkgartner, G., Wagner, D., Manhal, S., Fahrleitner-Pammer, A., Mischinger, H. J., Wagner, M., Grgic, R., Roller, R. E., Kniepeiss, D.

“…Due to ameliorated surgery as well as better immunosuppression, the recipient age after liver transplantation has been extended over the past years. This study…”
Get full text

Percutaneous endoscopic gastrostomy (PEG) : 8 years of clinical experience in 232 patients by AMANN, W, MISCHINGER, H. J, BERGER, A, ROSANELLI, G, SCHWEIGER, W, WERKGARTNER, G, FRUHWIRTH, J, HAUSER, H

“…Percutaneous endoscopic gastrostomy (PEG) is now a standard method for providing long-term enteral nutrition in patients who are unable to swallow. The aim of…”
Get full text

TUM2-PK (pyruvate kinase type tumor M2), CA19-9 and CEA in patients with benign, malignant and metastasizing pancreatic lesions by Cerwenka, H, Aigner, R, Bacher, H, Werkgartner, G, el-Shabrawi, A, Quehenberger, F, Mischinger, H J

“…The diagnostic value of the tumor marker pyruvate kinase type tumor M2 was evaluated in patients with benign, malignant and metastasizing pancreatic lesions…”
Get more information

Sarcopenia Negatively Influences Translocations of Gut Microbiome into the Pancreas and Biliary Tract in Patients with Pancreatic Adenocarcinoma by Wagner, D., Wienerroither, V., Werkgartner, G., Sucher, R., Kornprat, P.

Get full text

Treatment of patients with pyogenic liver abscess by Cerwenka, H, Bacher, H, Werkgartner, G, El-Shabrawi, A, Kornprat, P, Bernhardt, G A, Mischinger, H J

“…Pyogenic liver abscess (PLA) remains a serious disease with a mortality of 6-14%. Clinical data of 76 patients with PLA were analyzed. Treatment options…”
Get more information

Quality Assessment in Surgical RCTs for Liver Resection Techniques - Have We Met the Standard Yet? by Werkgartner, G., Bajric, T., Kornprat, P., Mischinger, H.J., Wagner, D.

Get full text

Sarcopenia Is Associated with Higher AFP Levels in Patients with Hepatocellular Carcinoma (HCC) by Bajric, T., Wagner, D., Werkgartner, G., Kornprat, P., Mischinger, H.J.

Get full text

Sarcopenia Negatively Impacts Recurrence Rates of CRLM after Liver Resection by Bajric, T., Wagner, D., Werkgartner, G., Kornprat, P., Mischinger, H.J.

Get full text

Quality assessment in surgical randomized controlled trials - have we met the standard yet? by Wagner, D., Kornprat, P., Werkgartner, G., Mischinger, H.J., Schemmer, P.

Get full text

Sarcopenic Obesity in Patients Undergoing Colorectal Liver Metastases (CRLM) Resection by Wagner, D., Faschinger, F., Wienerroither, V., Werkgartner, G., Sucher, R., Mischinger, H.J., Kornprat, P.

Get full text

Platelet to Lymphozyte Ratio in Patients Undergoing Resection for Pancreatic Neuroendocrine Tumors (PNET) by Wagner, D., Wienerroither, V., Werkgartner, G., Mischinger, H.J., Sucher, R., Kornprat, P.

Get full text

Normothermic liver ischemia and antioxidant treatment during hepatic resections by Cerwenka, H, Khoschsorur, G, Bacher, H, Werkgartner, G, El-Shabrawi, A, Quehenberger, F, Rabl, H, Mischinger, H J

“…The purpose of our study was to evaluate the clinical impact of reperfusion injury after normothermic ischemia during major liver resections and the effect of…”
Get more information

544 - Sarcopenia outperforms the Charlson Comorbidity Index in risk prediction in patients undergoing pancreatic resections by Wagner, D., Marsoner, K., Tomberger, A., Cerwenka, H., Werkgartner, G., Mischinger, H.J., Kornprat, P.

Get full text

Pancreatitis-associated protein (PAP) in patients with pancreatic cancer by Cerwenka, H, Aigner, R, Bacher, H, Werkgartner, G, el-Shabrawi, A, Quehenberger, F, Mischinger, H J

“…Pancreatitis-associated protein (PAP) is known as a marker for pancreatitis and cystic fibrosis. The aim of our study was to evaluate PAP in patients with…”
Get more information

Antioxidant treatment during liver resection for alleviation of ischemia-reperfusion injury by Cerwenka, H, Bacher, H, Werkgartner, G, El-Shabrawi, A, Quehenberger, F, Hauser, H, Mischinger, H J

“…Many experimental studies on ischemia-reperfusion injury in animals suggest a preventive effect of antioxidants, but the clinical significance of these…”
Get more information

Sarcopenic Obesity promotes invasive carcinomas in patients with IPMN or PANin by Wagner, D., Haybaeck, J., Tomberger, A., Waha, J., Werkgartner, G., Cerwenka, H., Kornprat, P., Mischinger, H.J.

Get full text